Liver X receptor activation promotes macrophage-to-feces reverse cholesterol transport in a dyslipidemic hamster model
Authors:
Open Access
- 1 April 2010
- journal article
- Published by Elsevier in Journal of Lipid Research
- Vol. 51 (4) , 763-770
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- LXR ligand lowers LDL cholesterol in primates, is lipid neutral in hamster, and reduces atherosclerosis in mouseJournal of Lipid Research, 2009
- LXRα activation perturbs hepatic insulin signaling and stimulates production of apolipoprotein B-containing lipoproteinsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2009
- LXR Regulates Cholesterol Uptake Through Idol-Dependent Ubiquitination of the LDL ReceptorScience, 2009
- Activation of the Liver X Receptor Stimulates Trans-intestinal Excretion of Plasma CholesterolJournal of Biological Chemistry, 2009
- The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosisJournal of Lipid Research, 2009
- Cholesterol Absorption From the Intestine Is a Major Determinant of Reverse Cholesterol Transport From Peripheral Tissue MacrophagesArteriosclerosis, Thrombosis, and Vascular Biology, 2008
- Liver X Receptor and Farnesoid X Receptor as Therapeutic TargetsThe American Journal of Cardiology, 2007
- Niemann–Pick C1 like 1 gene expression is down-regulated by LXR activators in the intestineBiochemical and Biophysical Research Communications, 2006
- Regulation of ATP-binding Cassette Sterol Transporters ABCG5 and ABCG8 by the Liver X Receptors α and βJournal of Biological Chemistry, 2002
- Kinetic parameters for high density lipoprotein apoprotein AI and cholesteryl ester transport in the hamster.Journal of Clinical Investigation, 1997